Patents by Inventor Tal Birnberg

Tal Birnberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treatment of Parkinson's disease
    Patent number: 11844754
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa, a levodopa salt, a levodopa prodrug, or any combination thereof, and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, a carbidopa salt, a carbidopa prodrug, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
    Type: Grant
    Filed: January 3, 2023
    Date of Patent: December 19, 2023
    Assignee: NeuroDerm, Ltd.
    Inventors: Tal Birnberg, Shmuel Ben Eliahu, Natalia Vostokova, Danit Finkelshtein Beker, Liat Adar, Itay Perlstein
  • METHODS FOR TREATMENT OF PARKINSON'S DISEASE
    Publication number: 20230157985
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g.
    Type: Application
    Filed: January 3, 2023
    Publication date: May 25, 2023
    Inventors: Tal Birnberg, Shmuel Ben Eliahu, Natalia Vostokova, Danit Finkelshtein Beker, Liat Adar, Itay Perlstein
  • METHOD FOR TREATMENT OF PARKINSON'S DISEASE
    Publication number: 20230064357
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson’s disease, in an individual in need thereof, by parenteral administration of levodopa and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
    Type: Application
    Filed: April 14, 2022
    Publication date: March 2, 2023
    Inventors: Tal Birnberg, Liat Adar, Itay Perlstein
  • Method for treatment of Parkinson's disease
    Patent number: 11458115
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
    Type: Grant
    Filed: May 4, 2022
    Date of Patent: October 4, 2022
    Assignee: NeuroDerm, Ltd.
    Inventors: Tal Birnberg, Liat Adar, Itay Perlstein
  • METHOD FOR TREATMENT OF PARKINSON'S DISEASE
    Publication number: 20220257549
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
    Type: Application
    Filed: May 4, 2022
    Publication date: August 18, 2022
    Inventors: Tal Birnberg, Liat Adar, Itay Perlstein
  • METHOD FOR TREATMENT OF PARKINSON'S DISEASE
    Publication number: 20220151965
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
    Type: Application
    Filed: November 23, 2021
    Publication date: May 19, 2022
    Inventors: Tal Birnberg, Liat Adar, Itay Perlstein
  • METHOD FOR TREATMENT OF PARKINSON'S DISEASE
    Publication number: 20220151967
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
    Type: Application
    Filed: January 3, 2022
    Publication date: May 19, 2022
    Inventors: Tal Birnberg, Liat Adar, Itay Perlstein
  • Method for treatment of Parkinson's disease
    Patent number: 11331293
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
    Type: Grant
    Filed: January 3, 2022
    Date of Patent: May 17, 2022
    Assignee: NeuroDerm, Ltd.
    Inventors: Tal Birnberg, Liat Adar, Itay Perlstein
  • Method for treatment of parkinson's disease
    Patent number: 11213502
    Abstract: Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
    Type: Grant
    Filed: May 28, 2021
    Date of Patent: January 4, 2022
    Assignee: NeuroDerm, Ltd.
    Inventors: Tal Birnberg, Liat Adar, Itay Perlstein